[{"indications": "Indications\u00a0see under Dose", "name": "NIZATIDINE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "1 Gastro-intestinal system", "1.3 Antisecretory drugs and mucosal protectants", "1.3.1 H2-receptor antagonists"], "cautions": "Cautions\u00a0see notes above; also avoid rapid intravenous\r\ninjection (risk of arrhythmias and postural hypotension); interactions: Appendix 1 (histamine H2-antagonists) and notes above", "side-effects": "Side-effects\u00a0see notes above; also sweating; rarely nausea, fever, vasculitis, hyperuricaemia", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2121.htm", "doses": ["Benign gastric, duodenal or NSAID-associated ulceration,\r\ntreatment, 300\u00a0mg in the evening or 150\u00a0mg twice\r\ndaily for 4\u20138 weeks; maintenance, 150\u00a0mg at night", "Gastro-oesophageal reflux disease, 150\u2013300\u00a0mg twice daily for\r\nup to 12 weeks", "child not recommended"], "pregnancy": "Pregnancy\u00a0manufacturer advises avoid unless essential"}]